GPCR Happy Hour Boston 2026 — April 29 | Dr. GPCR Community Event
- Yamina Berchiche
- Apr 15
- 3 min read
Updated: Apr 21
The community is gathering. No agenda. No presentations. Just your people, in one room.
Some of the best conversations in GPCR science don't happen at the podium. They happen in the hallway between sessions, at the coffee station, or in the ten minutes after a talk when someone finally says what they actually think. The problem is those moments are rare, rushed, and easy to miss.
That's why we created GPCR Happy Hour.
On April 29th, the Dr. GPCR community is gathering in Boston for an informal evening of real conversation. No presentations. No panels. No agenda. Just GPCR scientists in a room together, with food, drinks, and two hours to have the discussions that conferences don't make space for.
The evening takes place at Pressed Cafe, 105 Huntington Ave — steps from The Colonnade, where the 5th Annual GPCRs-Targeted Drug Discovery Summit is bringing together 80+ senior leaders across GPCR-focused biopharma from April 28–30. If you're attending the summit, join us right after Conference Day One wraps. If you're local to Boston, this is your chance to meet the community in person.
Space is limited to 50 scientists. Food and one drink ticket included. Cash bar available.
Why we keep it small
Fifty people is a deliberate choice. It's the size where you can actually talk to everyone in the room. Where a conversation that starts with one person pulls in three others. Where you walk away with a handful of connections that actually go somewhere, not a stack of business cards you'll never follow up on.
This is not a mixer. It's not a corporate reception. It's a gathering of people who already share something (a deep commitment to GPCR science) even if they're meeting for the first time.
Who's making the GPCR Happy Hour evening possible
GPCR Happy Hour is made possible by four companies that didn't just want to reach GPCR scientists, they wanted to be part of bringing the community together in person.
NIS | Founding Co-Host
NanoImaging Services (NIS) is a US-based structural biology partner offering a fully integrated gene-to-structure platform, with facilities in San Diego, CA and Woburn, MA.
Through their acquisition of Proteos, NIS combines two decades of recombinant protein production expertise, across mammalian, insect, and bacterial expression systems with high-resolution cryo-EM capabilities, including epitope mapping and structure determination of challenging targets like GPCRs and membrane protein complexes.
NIS is the kind of partner that understands what GPCR discovery actually requires at the structural level.
Want to learn more about NIS? Watch my conversation with their CSO Giovanna Scapin
Revvity | Founding Co-Host
Revvity is a global leader in life science innovation, delivering tools and technologies that bridge the gap between discovery and real-world impact. With decades of expertise and an unwavering focus on precision, Revvity empowers scientists to simplify complex workflows, accelerate discovery, and drive breakthroughs in drug development, diagnostics, and disease biology.
Whether you're decoding signaling pathways or designing the next generation of therapeutics,
Revvity brings the kind of platform-level support that serious GPCR programs depend on.
EuroscreenFast
EuroscreenFast has been a pioneer in GPCR science for more than 30 years,. The first company to offer access to recombinant GPCR assays. Today, their catalogue includes over 1,000 functional assays representing more than 550 GPCR and other targets, trusted by therapeutic developers worldwide for affinity, potency, efficacy, and functional selectivity studies.
Their deorphanisation track record (17 identified natural receptor-ligand pairs) speaks to the depth of their scientific investment in the field.
Montana Molecular
Montana Molecular is a leader in advanced GPCR assay technologies and services, combining genetically encoded fluorescent biosensors and BacMam gene delivery tools to measure the spatial and temporal signaling properties of drug candidates in living cells. Their platform delivers kinetic profiles that reliably inform decisions and reduce the risk and cost of developing new drugs, exactly the kind of intelligence GPCR programs need at the lead selection stage.
Who should come
This evening is open to pharma, biotech, academia, and students. If you work in GPCR science (or plan to) you belong in this room. Whether you've been following Dr. GPCR online for years or you're hearing about us for the first time, walk in. You already belong.
Employees of service providers or CROs: please inquire about co-hosting and vendor options at Hello@DrGPCR.org.
The details
📅 Wednesday, April 29, 2026
⏰ 6:00 PM – 8:00 PM
📍 Pressed Cafe, 105 Huntington Ave, Boston, MA (A two-minute walk from The Colonnade)
Food and one drink ticket included. Cash bar available after.
Space is limited to 50 scientists — registration is required.
This event is open to pharma, biotech, academia, and students.
Employees of service providers or CROs: please inquire about co-hosting and vendor options.
We'll see you April 29th.
Comments